Poly (d, l-lactide - co - glycolide ),raccordement ester, Mw 50 000 - 75 000

Code: 430471-1g D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

PLGA polymers find uses in the production of biodegradable medical sutures and for controlled drug release. PLGA microspheres have been reported for use in contro...


en savoir plus

Votre prix
$118.77 1G

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

PLGA polymers find uses in the production of biodegradable medical sutures and for controlled drug release. PLGA microspheres have been reported for use in controlled release of human growth hormone. Thin membranes of blended polymers constituting of PLGA/polycaprolactone/β-tricalcium phosphate have been used in guided bone regeneration.

Features and Benefits

Controlled release of bioactive agents, sutures and bioabsorbable implantable devices.

General description

Characteristic properties of ester terminated poly(D,L-lactide-co-glycolide) (PLGA) are in vivo biodegradability, tunable drug release profile and very high encapsulation capacity.

Legal Information

Lactel is a registered trademark of Durect Corp.

Packaging

1, 5 g in glass bottle

Physical form

Biocompatible, biodegradable polymer.

degradation timeframe﹤6 months
feed ratiolactide:glycolide 85:15
formamorphous
mol wtMw 50,000-75,000
Quality Level100
SMILES stringOCC(O)=O.CC(O)C(O)=O
solubilityethyl acetate, chloroform, acetone and THF: soluble
storage temp.2-8°C
transition tempTg 45-50 °C
viscosity0.55-0.75 dL/g, 0.1 % (w/v) in chloroform(25 °C)
Code
Description
Unité de vente
Prix annoncé
Qté
430471-5G
Unité:5G
Prix annoncé: $408.26
Source:Prix annoncé
Cas Number26780-50-7
Ce produit répond aux critères suivants: